4//SEC Filing
Poddar Richa 4
Accession 0001439222-22-000003
CIK 0001439222other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:06 PM ET
Size
8.3 KB
Accession
0001439222-22-000003
Insider Transaction Report
Form 4
Poddar Richa
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2022-02-10+2,068→ 2,218 total - Exercise/Conversion
Restricted stock units
2022-02-10−2,068→ 4,136 total→ Common stock (2,068 underlying) - Tax Payment
Common stock
2022-02-10$31.43/sh−725$22,783→ 1,493 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001897274
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:06 PM ET
- Size
- 8.3 KB